Kirk Perry - 01 Jul 2026 Form 4 Insider Report for J M SMUCKER Co (SJM)

Reporting relationship: Director
Issuer ticker: SJM
Reported as of: 01 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jul 2026, 16:32:33 UTC
Prior SEC filing: 03 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Jeannette L. Knudsen, POA

Key filing fact

Kirk Perry filed Form 4 for J M SMUCKER Co (SJM) on 02 Jul 2026.

Key facts

This page summarizes Kirk Perry's Form 4 filing for J M SMUCKER Co (SJM).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Jul 2026, 16:32.

Change

Previous filing in this sequence was filed on 03 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001685154 Primary reporting owner

Perry Kirk

Relationship: Director
Address: ONE STRAWBERRY LANE, ORRVILLE
Signature: /s/ Jeannette L. Knudsen, POA
Signature date: 02 Jul 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SJM transaction Derivative

Deferred Stock Units

Award

Transaction value
Shares: +218
Change %: +0.96%
Price: $0.000000^*
Shares after: 22,991
Date: 01 Jul 2026
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 218
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Deferred Stock Units are payable in Common Shares at a rate of 1-for-1 following termination of services as a director.

Footnote F2

This amount includes shares acquired under the Company's dividend reinvestment plan, as administered by its transfer agent.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .